Basel Medical Group Ltd
BMGL
$2.02
-$0.17-7.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.08% | -143.60% | -0.97% | -43.37% | 0.00% |
| Total Depreciation and Amortization | -1.13% | 36.86% | -0.92% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.04% | -2.02% | 0.95% | -253.14% | 0.00% |
| Change in Net Operating Assets | 1.09% | -327.63% | -0.97% | 200.35% | 0.00% |
| Cash from Operations | 1.09% | -264.50% | -0.97% | 1,555.53% | 0.00% |
| Capital Expenditure | 1.43% | -- | -- | 100.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.97% | -- | -- | -- | -- |
| Cash from Investing | -0.74% | -- | -- | 100.00% | 0.00% |
| Total Debt Issued | 0.00% | 1,515.64% | 0.00% | -40.18% | 0.00% |
| Total Debt Repaid | 0.00% | -297.01% | 0.00% | 12.51% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 3,932.51% | 0.00% | -138.68% | 0.00% |
| Cash from Financing | -1.09% | 800.06% | 0.97% | -233.51% | 0.00% |
| Foreign Exchange rate Adjustments | 2.17% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.09% | 459.86% | -0.96% | 470.25% | 0.00% |